| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/06/2002 | EP1177791A2 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177186A1 Ureas and their use as cell adhesion modulators |
| 02/06/2002 | EP1177172A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
| 02/06/2002 | EP1177171A1 Substituted indole sulfonamides as antiviral agents |
| 02/06/2002 | EP1176987A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/06/2002 | CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors |
| 02/06/2002 | CN1334803A Method for producing (2S, 4R, 9S)-octahydro-1H-indole-2-carboxylic acid and intermediate products therefor |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2002 | CN1078889C Non-pepitde tachykinin receptor antagonists |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344467 Antiasthmatic, antiallergic and immunosuppressant/immunomodulating properties |
| 02/05/2002 | US6344457 Rheumatoid arthritis, osteoarthritis, osteoporosis, corneal ulceration, periodontitis, gingivitis or tumorous invasion and metastatic proliferation, atherosclerosis, aids, chronic inflammatory diseases of the intestine |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | CA2217513C Pharmaceutical agents for the treatment of alzheimer's disease |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 02/05/2002 | CA2081330C 3-indolyl thioacetate derivatives |
| 02/01/2002 | CA2354275A1 Process for preparing basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 01/31/2002 | WO2002008236A1 Ligands, complex compounds and their use for polymerising olefins |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002008188A1 N-substituted indoles useful in the treatment of diabetes |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008186A2 Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2002008169A1 Ruthenium complexes and their use in asymmetric hydrogenation |
| 01/31/2002 | WO2002007720A1 Compounds having mif antagonist activity |
| 01/31/2002 | WO2001055066A3 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides |
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | US20020013358 Indole derivatives |
| 01/31/2002 | US20020013352 Novel substituted diamine derivatives useful as motilin antagonists |
| 01/31/2002 | US20020013296 Treating with agonists at kappa opioid receptors such as methyl-4-(2-glycyl-4-(trifluoromethylphenyl)acetyl)-3-(R,S)-((1 -pyrrolidinyl)-methyl)-1-piperazinecarboxylate |
| 01/31/2002 | US20020010968 Composition for dyeing keratin fibers with a cationic direct dye and a thickening |
| 01/31/2002 | DE10035654A1 Liganden, Komplexverbindungen und ihre Verwendung zur Polymerisation von Olefinen Ligand complex compounds and their use for the polymerization of olefins |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416750A1 Compounds having mif antagonist activity |
| 01/31/2002 | CA2415742A1 N-substituted indoles useful in the treatment of diabetes |
| 01/31/2002 | CA2415738A1 Ruthenium complexes and their use in asymmetric hydrogenation |
| 01/31/2002 | CA2411192A1 Combination of serotonin agonist (5ht2) and antagonist (5ht6)as a pharmaceutical formulation |
| 01/31/2002 | CA2410682A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2354236A1 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/30/2002 | EP1175399A1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP1175397A1 3,3-substituted indoline derivatives |
| 01/30/2002 | EP0934267B1 Alpha-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/30/2002 | CN1333774A Substituted benzofuranodindoles and indenoindoles as novel potassium channel openers |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1333206A Sulfuryl diphenyl indole compound and preparation process and use in medicine |
| 01/30/2002 | CN1332962A Process for prepairng weedicide imidazolinone compound |
| 01/30/2002 | CN1078590C Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles |
| 01/29/2002 | US6342637 Diamine hole transport agent and organic electroluminescent device containing same |
| 01/29/2002 | US6342599 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/29/2002 | US6342531 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | US6342335 Polymethine compounds, method of producing same, and use thereof |
| 01/29/2002 | CA2093322C Epoxy resins based on diaminobisimide compounds |
| 01/24/2002 | WO2002006280A2 INHIBITORS OF FACTOR Xa |
| 01/24/2002 | WO2002006273A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 01/24/2002 | WO2002006227A1 Matrix metalloprotease inhibitors |
| 01/24/2002 | WO2002006226A1 Processes for preparation of fused pyrroles |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002006210A1 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005819A1 Compounds and methods |
| 01/24/2002 | WO2002005796A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | WO2001060814A3 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001038305A3 Novel il-8 receptor antagonists |
| 01/24/2002 | WO2001029000A3 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010286 Multifunctional cyanate ester and epoxy blends |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010203 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 01/24/2002 | US20020008229 Polyerized crystalline colloid array |
| 01/24/2002 | CA2415126A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 01/24/2002 | CA2413582A1 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/23/2002 | EP1174426A1 Method for the preparation of tricyclic amino alcohol derivatives through azides |
| 01/23/2002 | EP1174425A1 Novel method for manufacturing tricyclic amino alcohol derivatives |
| 01/23/2002 | EP1173519A1 Novel carbopyronine fluorescence dyes |
| 01/23/2002 | EP1173421A2 Indole derivatives as anti-inflammation agents |
| 01/23/2002 | EP1173415A1 Diphenylurea derivatives |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173212A1 Contraceptive compositions contaning indolone derivatives and progestational agents |
| 01/23/2002 | EP1173211A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof |
| 01/23/2002 | CN1332752A Method of producing derivatized polymers |
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/23/2002 | CN1332638A Combination comprising beta-agonist and further antidiabetic agent |
| 01/23/2002 | CN1332157A Carbazole alkaloid derivative and its prepn and use |
| 01/22/2002 | US6340745 Phthalocyanine and use of phthalocyanine as a marking agent |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/22/2002 | US6340699 SPLA2 inhibitor compounds for treatment of disease |
| 01/22/2002 | US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340587 Treating racemic mixture with acylase; isolating pure enantiomorph of n-protected (1r,4s)-2-azabicyclo(2.2.1)hept-5-en-3-one |